From 542372f5989a8caa96168f2a14e35079d1501cf1 Mon Sep 17 00:00:00 2001 From: Marta Girona Alarcon <marta.gironaalarcon@uzh.ch> Date: Thu, 3 Oct 2024 13:35:42 +0200 Subject: [PATCH] update --- .../Publication_page.qmd | 17 +++++++++++------ 1 file changed, 11 insertions(+), 6 deletions(-) diff --git a/webpage_contents/publications/20240901_Marta_GironaAlarcon/Publication_page.qmd b/webpage_contents/publications/20240901_Marta_GironaAlarcon/Publication_page.qmd index 62c0ef5..68e8d84 100644 --- a/webpage_contents/publications/20240901_Marta_GironaAlarcon/Publication_page.qmd +++ b/webpage_contents/publications/20240901_Marta_GironaAlarcon/Publication_page.qmd @@ -57,18 +57,23 @@ In the publication, we have shown the need of infusing contrast agent to achieve {width="900"} ### Calibration ramp + ::: {layout-ncol=5} - +{fig-caption="0 mg Ba/mL"} + +{fig-caption="48 mg Ba/mL"} - +{fig-caption="120 mg Ba/mL"} - +{fig-caption="158.4 mg Ba/mL"} - +{fig-caption="240 mg Ba/mL"} +::: - +::: {.figure} +Fig. 3. *In vitro* calibration scans used for the calibration ramp presented in Experiment 3. Tubes containing different dilutions of CA resulting in a final concentration of 0, 48, 120, 158.4, and 240 mg Ba/mL (left to right). ::: -~Fig. 3. *In vitro* calibration scans used for the calibration ramp presented in Experiment 3. Tubes containing different dilutions of CA resulting in a final concentration of 0, 48, 120, 158.4 and 240 mg Ba/mL (left to right)~ + ### Timeseries movies -- GitLab